Liver Cancer

Meet leading physician, researcher and passionate advocate Guadalupe “Lupe” Garcia-Tsao, MD, FRCP. Dr. Garcia-Tsao is Professor of Medicine at Yale University School of Medicine and Chief of Digestive Diseases at the VA-Connecticut Healthcare System.

The American Liver Foundation reached out to top doctors Ghassan K. Abou-Alfa, MD, and Ronald P. DeMatteo, MD., to get answers to the most commonly asked liver cancer questions.

Meet Ryan Clary, Former Executive Director of the National Viral Hepatitis Roundtable and longtime HIV and AIDS advocate who has dedicated his life to giving a voice to liver patients.

Did you know rates of liver cancer incidence have more than tripled since 1980? During this time, death rates have more than doubled.

A new comprehensive study shows overall cancer deaths are down, but with liver cancer as the concerning exception.

Liver cancer is the growth and spread of unhealthy cells in the liver. Cancer that starts in the liver is primary liver cancer.

Liver cancer strikes 33,000 Americans annually, according to the American Cancer Society and it is expected that 23,000 Americans will die as a result of liver cancer this year.